Further, survival analysis indicated that a low level of FECH expression was significantly correlated with shorter OS and DFS in ccRCC patients (Fig. 7J, K), which corresponded to the survival analysis of SETD2 (1I, 1J). The gene discussed is FECH; the disease is nonpapillary renal cell carcinoma.